Enhanced paracrine action of FGF21 in stromal cells delays thymic aging
Yun‐Hee Youm, Christy Gliniak, Yuan Zhang, Tamara Dlugos, Philipp E. Scherer, Vishwa Deep Dixit
Abstract
Age-related thymic involution precedes aging of all other organs in vertebrates and initiates the process of declining T cell diversity, which leads to eventual immune dysfunction. Whether FGF21, a liver-derived pro-longevity hormone that is also produced in thymic stroma, including by adipocytes, controls the mechanism of thymic demise is incompletely understood. Here, we demonstrate that elevation of FGF21 in thymic epithelial cells (TECs) and in adipocytes protects against thymic aging, whereas conditional hepatic overexpression did not impact thymic biology in aged mice. Notably, elevation of thymic FGF21 increased naïve CD8 T cells in aged animals and extended healthspan. Mechanistically, thymic FGF21 overexpression elevated TECs and reduced fibroadipogenic cells. Ablation of β-klotho, the obligatory co-receptor for FGF21 in Foxn1+ TECs, accelerated thymic aging, suggesting regulation of TECs by FGF21 is partially required for thymic lymphopoiesis. These findings establish that paracrine FGF21 improves thymic function and delays immune aging. Youm et al. demonstrate that elevating locally derived FGF21 delays thymic aging and extends organismal healthspan, dependent in part on expression of the FGF21 co-receptor β-klotho on thymic epithelial cells.